Giuliano Netto Flores Cruz

Giuliano Netto Flores Cruz

Auto-generated profile, based on publicly available information

Giuliano Netto Flores Cruz

Centre for Molecular Medicine and Therapeutics, British Columbia Children’s Hospital Research Institute, Vancouver, Canada

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ACAna Christoff
Ana Christoff
GCGiuliano Netto Flores Cruz
Giuliano Netto Flores Cruz
ASAline Fernanda Rodrigues Sereia
Aline Fernanda Rodrigues Sereia
DBDellyana Rodrigues Boberg
Dellyana Rodrigues Boberg
DBDaniela Carolina de Bastiani
Daniela Carolina de Bastiani
LOLuiz Felipe Valter de Oliviera
Luiz Felipe Valter de Oliviera
To minimize sample dilution effect on SARS-CoV-2 pool testing, we assessed analytical and diagnostic performance of a new methodology, namely swab pooling. In this method, swabs are pooled at the time of collection, as opposed to pooling of equal volumes from individually collected samples. Paired analysis of pooled and individual samples from 613 patients revealed 94 positive individuals. Having individual testing as reference, no false-positives or false-negatives were observed for swab pooling. In additional 18,922 patients screened with swab pooling (1,344 pools), mean Cq differences between individual and pool samples ranged from 0.1 (Cr.I. -0.98 to 1.17) to 2.09 (Cr.I. 1.24 to 2.94). Overall, 19,535 asymptomatic patients were screened using 4,400 RT-qPCR assays. This corresponds to an increase of 4.4 times in laboratory capacity and a reduction of 77% in required tests. Therefore, swab pooling represents a major alternative for reliable and large-scale screening of SARS-CoV-2 in low prevalence populations.

30 December 2024 in Statistics in Medicine
Verified
Journal Article
Open access
GCGiuliano Netto Flores Cruz
Giuliano Netto Flores Cruz
KKKeegan Korthauer
Keegan Korthauer
Clinical decisions are often guided by clinical prediction models or diagnostic tests. Decision curve analysis (DCA) combines classical assessment of predictive performance with the consequences of using these strategies for clinical decision‐making. In DCA, the best decision strategy is the one that maximizes the net benefit: the net number of true positives (or negatives) provided by a given strategy. Here, we employ Bayesian approaches to DCA, addressing four fundamental concerns when evaluating clinical decision strategies: (i) which strategies are clinically useful, (ii) what is the best available decision strategy, (iii) which of two competing strategies is better, and (iv) what is the expected net benefit loss associated with the current level of uncertainty. While often consistent with frequentist point estimates, fully Bayesian DCA allows for an intuitive probabilistic interpretation framework and the incorporation of prior evidence. We evaluate the methods using simulation and provide a comprehensive case study. Software implementation is available in the bayesDCA R package. Ultimately, the Bayesian DCA workflow may help clinicians and health policymakers adopt better‐informed decisions.

3 February 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
GCGiuliano Netto Flores Cruz
Giuliano Netto Flores Cruz
ACAna Christoff
Ana Christoff
LOLuiz Felipe Valter de Oliviera
Luiz Felipe Valter de Oliviera
Next-generation sequencing (NGS) has been extensively employed to perform microbiome characterization worldwide. As a culture-independent methodology, it has allowed high-level profiling of sample microbial composition. However, most studies are limited to information regarding relative bacterial abundances, ignoring scenarios in which sample microbe biomass can vary widely. Here, we develop an equivolumetric protocol for amplicon library preparation capable of generating NGS data responsive to input DNA, recovering proportionality between observed read counts and absolute bacterial abundances. Under specified conditions, we argue that the estimation of colony-forming units (CFU), the most common unit of bacterial abundance in classical microbiology, is challenged mostly by resolution and taxon-to-taxon variation. We propose Bayesian cumulative probability models to address such issues. Our results indicate that predictive errors vary consistently below one order of magnitude for observed bacteria. We also demonstrate our approach has the potential to generalize to previously unseen bacteria, but predictive performance is hampered by specific taxa of uncommon profile. Finally, it remains clear that NGS data are not inherently restricted to relative information only, and microbiome science can indeed meet the working scales of traditional microbiology.

11 February 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
WLWilliam Lopes
William Lopes
GCGiuliano N F Cruz
Giuliano N F Cruz
Marcio RodriguesMarcio Rodrigues
Marcio Rodrigues
MVMendeli H Vainstein
Mendeli H Vainstein
LKLívia Kmetzsch
Lívia Kmetzsch
ASAugusto Schrank
Augusto Schrank
Phenotypic heterogeneity is an important trait for the development and survival of many microorganisms including the yeast Cryptococcus spp., a deadly pathogen spread worldwide. Here, we have applied scanning electron microscopy (SEM) to define four Cryptococcus spp. capsule morphotypes, namely Regular, Spiky, Bald, and Phantom. These morphotypes were persistently observed in varying proportions among yeast isolates. To assess the distribution of such morphotypes we implemented an automated pipeline capable of (1) identifying potentially cell-associated objects in the SEM-derived images; (2) computing object-level features; and (3) classifying these objects into their corresponding classes. The machine learning approach used a Random Forest (RF) classifier whose overall accuracy reached 85% on the test dataset, with per-class specificity above 90%, and sensitivity between 66 and 94%. Additionally, the RF model indicates that structural and texture features, e.g., object area, eccentricity, and contrast, are most relevant for classification. The RF results agree with the observed variation in these features, consistently also with visual inspection of SEM images. Finally, our work introduces morphological variants of Cryptococcus spp. capsule. These can be promptly identified and characterized using computational models so that future work may unveil morphological associations with yeast virulence.

5 September 2020 in medRxiv
Verified
Preprint
Open access
PDF file
ACAna Christoff
Ana Christoff
GCGiuliano Netto Flores Cruz
Giuliano Netto Flores Cruz
ASAline Fernanda Rodrigues Sereia
Aline Fernanda Rodrigues Sereia
DBDellyana Rodrigues Boberg
Dellyana Rodrigues Boberg
DBDaniela Carolina de Bastiani
Daniela Carolina de Bastiani
LOLuiz Felipe Valter de Oliviera
Luiz Felipe Valter de Oliviera
Pool testing has been proposed as an alternative for large-scale SARS-CoV-2 screening. However, dilution factors proportional to the number of pooled samples have been a source of major concern regarding its diagnostic performance. Further, sample pooling can lead to increased laboratory workload and operational complexity. Therefore, pooling strategies that minimize sample dilution, loss of sensitivity, and laboratory overload are needed to allow reliable and large-scale screenings of SARS-CoV-2. Here, we describe a pooling procedure in which nasopharyngeal swabs are pooled together at the time of sample collection (swab pooling), decreasing laboratory manipulation and minimizing dilution of the viral RNA present in the samples. Paired analysis of pooled and individual samples from 613 patients revealed 94 positive individual tests. Having individual testing as a reference, no false-positives or false-negatives were observed for swab pooling. A Bayesian model estimated a sensitivity of 99% (Cr.I. 96.9% to 100%) and a specificity of 99.8% (Cr.I. 99.4% to 100%) for the swab pooling procedure. Data from additional 18,922 patients screened with swab pooling were included for further quantitative analysis. Mean Cq differences between individual and corresponding pool samples ranged from 0.1 Cq (Cr.I. –0.98 to 1.17) to 2.09 Cq (Cr.I. 1.24 to 2.94). Overall, 19,535 asymptomatic and presymptomatic patients were screened using 4,400 RT-qPCR assays, resulting in 246 positive patients (positivity rate 1.26%). This corresponds to an increase of 4.4 times in laboratory capacity and a reduction of 77% in required tests. Finally, these data demonstrate that swab pooling can significantly minimize sample dilution and sensitivity issues commonly seen in its traditional counterpart. Therefore, swab pooling represents a major alternative for reliable and large-scale screening of SARS-CoV-2 in low prevalence populations.

3 May 2020 in Research Square
Verified
Preprint
Open access
PDF file
GCGiuliano Netto Flores Cruz
Giuliano Netto Flores Cruz
ACAna Paula Christoff
Ana Paula Christoff
LOLuiz Felipe Valter de Oliviera
Luiz Felipe Valter de Oliviera
Background Next-generation sequencing (NGS) has been extensively employed to perform microbiome characterization worldwide. As a culture-independent methodology, it has allowed high-level profiling of sample microbial composition. However, most studies are limited to sample information regarding relative bacterial abundances (sample proportions), ignoring scenarios in which sample microbe biomass can vary widely. Here, we develop an equivolumetric protocol for amplicon library preparation capable of generating NGS data responsive to input DNA, recovering proportionality between observed read counts and absolute bacterial abundances within each sample. Within a determined range, we show that the estimation of sample colony-forming units (CFU), the most common unit of bacterial abundance in classical microbiology, is challenged mostly by resolution and taxon-to-taxon variation. We propose Bayesian cumulative probability models to address such issues.Results Observed read counts were consistently proportional to input DNA, total microbial load, and bacterium-specific sample abundances, although a saturation tendency was observed as abundances increased. Using Bayesian cumulative probability models, predictive errors in sample CFU estimation varied constantly below one order of magnitude - as measured by the mean absolute log10-ratio (MALR). For total microbial load, observed MALR was no greater than 0.2 during both cross-validation and validation on a test dataset. For observed bacteria, estimation of taxon-specific CFU showed MALR values of at most 0.5. We also performed leave-one-group-out cross-validation to assess predictive performance for previously unseen bacteria. While most bacteria showed MALR no greater than 1, such a threshold was exceeded only by Bacillus cereus.Conclusions Being able to estimate sample CFU in a high-throughput fashion has a wide range of applications, from the study of built environments to public health surveillance. This study shows that equivolumetric protocols along with cumulative probability models allow sample CFU estimation from microbiome datasets. Further, our approach has the potential to generalize to previously unmodeled bacteria, an important feature in high-throughput settings. Lastly, it remains clear that NGS data are not inherently restricted to sample proportions only, and microbiome science can finally meet the working scales of classical microbiology.